- The University Program in Genetics and Genomics (UPGG). Duke University, NC, USA. March 13, 2012.
- Epigenetics: Bench to Bedside. European Union COST program. Riga, Latvia. April 26-27, 2012 (keynote speaker).
- Institute of Biotechnology and Vilnius University. EU Mobilis program. Vilnius, Lithuania. May 3, 2012.
- 16th International Congress on Parkinson Disease and Movement Disorders. Dublin, Ireland. June 17-21, 2012.
- Epigenetic regulation: from mechanism to intervention. MRC Clinical Sciences Centre. London, UK. June 20-22, 2012.
- Institute of Psychiatry. King’s College London. London UK. June 28, 2012.
- Summer Undergraduate Research Program, University of Toronto. Medical Science Building, Toronto. July 20, 2012.
- Albert Einstein College of Medicine of Yeshiva University. Bronx, New York, USA. August 10, 2012.
- NIH Common Fund meeting “Epigenomic Surrogates for Difficult to Access Tissues”. Bethesda MD. USA. August 28, 2012.
- Agricultural Biotechnology Center – Godolo. Budapest, Hungary. September 26, 2012.
- Epigenetics: Opportunities for Sleep and Circadian Research. Philadelphia, PA, USA. October 3-5, 2012.
- Epigenomics of Common Diseases. Johns Hopkins University, Baltimore MD, USA. October 12 – 15, 2012.
- Postgenomic methods of analysis in biology, and laboratory and clinical medicine. Kazan Federal University, Kazan, Russia. November 22-24, 2012.
How To Help
We are doing cutting-edge research to understand how the environment affects schizophrenia genes, and how proteins in your brain could be the key to permanently treating schizophrenia. You can help us with this critical work by making a generous contribution.
View the Laboratory
The goal and motivation for Dr. Liu's research is to discover a new treatment for human brain disease that is translated into an actual drug. It is a simple goal but of course very challenging to achieve.
